Characteristics of Depression Remission and Its Relation With Cardiovascular Outcome Among Patients With Chronic Heart Failure (from the SADHART-CHF Study)

被引:87
作者
Jiang, Wei [1 ,2 ]
Krishnan, Ranga [2 ]
Kuchibhatla, Maragatha [3 ]
Cuffe, Michael S. [1 ]
Martsberger, Carolyn [2 ]
Arias, Rebekka M. [4 ]
O'Connor, Christopher M. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Ctr Aging, Durham, NC 27710 USA
[4] Duke Clin Res Inst, Durham, NC USA
关键词
LONG-TERM MORTALITY; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; ENHANCING RECOVERY; PLACEBO-RESPONSE; SYMPTOMS; SERTRALINE; EFFICACY; COMMUNICATION; PREDICTORS;
D O I
10.1016/j.amjcard.2010.10.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depression is prevalent in patients with heart failure and is associated with a significant increase in hospitalizations and death. Primary results of the Sertraline Against Depression and Heart Disease in Chronic Heart Failure (SADHART-CHF) trial revealed that sertraline and placebo had comparable effects on depression and cardiovascular outcomes. In this study, we explored whether remission from depression was associated with better survival and aimed to characterize participants who remitted during the trial. Based on depression response during the 12-week treatment phase, SADHART-CHF participants were divided into 2 groups: (1) remission, defined as participants whose last measured Hamilton Depression Rating Scale (HDRS) score was < 8, and (2) nonremission, defined as participants whose last measured HDRS score was >= 8 Patients who dropped out before having any repeat HDRS were not included. Baseline characteristics and survival differences up to 5 years were evaluated between the remission and nonremission groups. Of the 469 SADHART-CHF participants, 208 (44.3%) achieved remission, 194 (41.4%) remained depressed, and 67 (14.3%) dropped out or died without any repeat HDRS assessment. Patients in the remission group had significantly fewer cardiovascular events than those in the nonremission group (1.34 +/- 1.86 vs 1.93 +/- 2.71, adjusted p = 0.01). Men patients were more likely to remit than women patients (56.5 vs 44.8%, p = 0.02). The remission group had milder depressive symptoms at baseline compared to the nonremission group (HDRS 17.0 +/- 5.4 vs 19.6 +/- 5.5, Beck Depression Inventory scale 17.9 +/- 6.5 vs 20.3 +/- 7.2, p <0.001 for the 2 comparisons). In conclusion, this study indicates that remission from depression may improve the cardiovascular outcome of patients with heart failure. (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:545-551)
引用
收藏
页码:545 / 551
页数:7
相关论文
共 30 条
[1]  
Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
[2]   Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study [J].
Carney, RM ;
Blumenthal, JA ;
Freedland, KE ;
Youngblood, M ;
Veith, RC ;
Burg, MM ;
Cornell, C ;
Saab, PG ;
Kaufmann, PG ;
Czajkowski, SM ;
Jaffe, AS .
PSYCHOSOMATIC MEDICINE, 2004, 66 (04) :466-474
[3]  
Frasure-Smith N, 1995, J Cardiopulm Rehabil, V15, P103
[4]   Sertraline treatment of major depression in patients with acute MI or unstable angina [J].
Glassman, AH ;
O'Connor, CM ;
Califf, RM ;
Swedberg, K ;
Schwartz, P ;
Bigger, JT ;
Krishnan, KRR ;
van Zyl, LT ;
Swenson, JR ;
Finkel, MS ;
Landau, C ;
Shapiro, PA ;
Pepine, CJ ;
Mardekian, J ;
Harrison, WM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (06) :701-709
[5]   Psychiatric Characteristics Associated With Long-term Mortality Among 361 Patients Having an Acute Coronary Syndrome and Major Depression Seven-Year Follow-up of SADHART Participants [J].
Glassman, Alexander H. ;
Bigger, J. Thomas, Jr. ;
Gaffney, Michael .
ARCHIVES OF GENERAL PSYCHIATRY, 2009, 66 (09) :1022-1029
[6]   Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure [J].
Jiang, Wei ;
O'Connor, Christopher ;
Silva, Susan G. ;
Kuchibhatla, Maragatha ;
Cuffe, Michael S. ;
Callwood, Dwayne D. ;
Zakhary, Bosh ;
Henke, Elizabeth ;
Arias, Rebekka M. ;
Krishnan, Ranga .
AMERICAN HEART JOURNAL, 2008, 156 (03) :437-444
[7]   Congestive heart failure - Relationship between depressive symptoms and long-term mortality in patients with heart failure [J].
Jiang, Wei ;
Kuchibhatla, Maragatha ;
Clary, Greg L. ;
Cuffe, Michael S. ;
Christopher, Eric J. ;
Alexander, Jude D. ;
Califf, Robert M. ;
Krishnan, Ranga R. ;
O'Connor, Christopher M. .
AMERICAN HEART JOURNAL, 2007, 154 (01) :102-108
[8]   Depressive symptoms and six-year cardiovascular mortality in elderly patients with and without heart failure [J].
Johansson, P. ;
Dahlstrom, U. ;
Alehagen, U. .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2007, 41 (05) :299-307
[9]  
Katz J., 1984, SILENT WORLD DOCTOR
[10]   Placebo response and antidepressant clinical trial outcome [J].
Khan, A ;
Detke, M ;
Khan, SRF ;
Mallinckrodt, C .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 2003, 191 (04) :211-218